Spinocerebellar Ataxia Type 7 Latest Advances

Find the Latest Research About Spinocerebellar Ataxia Type 7

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications

Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker.

Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker.

Journal: International journal of molecular sciences
Published: November 30, 2025

Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7.

Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7.

Journal: International journal of molecular sciences
Published: March 14, 2025

In Silico Analysis of miRNA-Regulated Pathways in Spinocerebellar Ataxia Type 7.

In Silico Analysis of miRNA-Regulated Pathways in Spinocerebellar Ataxia Type 7.

Journal: Current issues in molecular biology
Published: December 31, 2024

Correction: Long-Term Follow-Up Before and During Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.

Correction: Long-Term Follow-Up Before and During Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.

Journal: Cerebellum (London, England)
Published: September 13, 2024

Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease.

Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease.

Journal: International journal of molecular sciences
Published: August 31, 2024

Retinal degeneration in spinocerebellar ataxia type 7: an overview of the current knowledge.

Retinal degeneration in spinocerebellar ataxia type 7: an overview of the current knowledge.

Journal: Arquivos brasileiros de oftalmologia
Published: August 22, 2024

Increased nuclear import characterizes aberrant nucleocytoplasmic transport in neurons from patients with spinocerebellar ataxia type 7.

Increased nuclear import characterizes aberrant nucleocytoplasmic transport in neurons from patients with spinocerebellar ataxia type 7.

Journal: Frontiers in molecular neuroscience
Published: August 17, 2024

Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7.

Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7.

Journal: Molecular therapy. Nucleic acids
Published: July 06, 2024

Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.

Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.

Journal: Cerebellum (London, England)
Published: June 17, 2024

Generation of human induced pluripotent stem cell lines (LUMCi051-A,B and LUMCi052-A,B,C) of two patients with Spinocerebellar ataxia type 7.

Generation of human induced pluripotent stem cell lines (LUMCi051-A,B and LUMCi052-A,B,C) of two patients with Spinocerebellar ataxia type 7.

Journal: Stem cell research
Published: April 17, 2024

Progressive degeneration in a new Drosophila model of Spinocerebellar Ataxia type 7.

Progressive degeneration in a new Drosophila model of Spinocerebellar Ataxia type 7.

Journal: Research square
Published: December 04, 2023

Progressive degeneration in a new Drosophila model of Spinocerebellar Ataxia type 7.

Progressive degeneration in a new Drosophila model of Spinocerebellar Ataxia type 7.

Journal: bioRxiv : the preprint server for biology
Published: November 21, 2023
Showing 1-12 of 211

Last Updated: 04/28/2026